Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leitat is a leading Spanish non-profit technology center specializing in R&D services for the life sciences sector. It provides preclinical research and development for biomedicine—including drug discovery/validation (oncology focus), biomarker identification/validation, monoclonal antibody generation/engineering (including ADCs and bispecifics), gene/cell therapies production support under GMP standards. Through its subsidiary Gene Vector Barcelona and collaborations such as CERTERA Consortium projects with Hospital Clínic de Barcelona on CAR-T therapies like varnimcabtagene autoleucel ("var-cel"), it has contributed to Phase 2 multinational clinical trials for relapsed/refractory acute lymphoblastic leukemia. Most activities remain at the preclinical or early clinical stage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leitat.